What is Neogen's cumulative cost basis?

Neogen (NEOG) reported cumulative cost basis of $494.56M in Q1 2025.

What is the long-term trend for Neogen's cumulative cost basis?

Over 4 years (2021 to 2025), Neogen's cumulative cost basis has grown at a 25.7% compound annual growth rate (CAGR), from $198.26M to $494.56M.

Neogen NEOG Cumulative Cost Basis

Cumulative Cost Basis at other companies

Where Food Comes FromWFCF

——

Bio-Rad LaboratoriesBIO

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$211.2M-4.4%

Gross profit$99.0M-10.2%

Operating income-$3.3M-161%

Net income-$17.0M-56.0%

EPS (diluted)-$0.08-60.0%

Balance sheet

See full

Cash & equivalents$159.9M+25.2%

Total debt$793.3M-11.2%

Total equity$2.1B-21.0%

Total assets$3.4B-16.8%

Cash flow

See full

Operating cash flow$22.7M+16.7%

CapEx$11.6M-64.7%

Free cash flow$11.1M+182%

Valuation

See full

Market cap$1.96B+95.6%

Enterprise value$2.59B+46.1%

P/S2.3×+1.1×

Profitability

See full

Gross margin45.2%-3.6pp

Operating margin-73.1%+77.7pp

Net margin-69.9%+30.8pp

FCF margin-14%—

Returns & leverage

See full

Return on equity-25.6%+28.8pp

Debt / equity0.4×0.0×

Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Neogen’s 10-K, filed July 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Neogen's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neogen's cumulative cost basis?: Neogen (NEOG) reported cumulative cost basis of $494.56M in Q1 2025.
What is the long-term trend for Neogen's cumulative cost basis?: Over 4 years (2021 to 2025), Neogen's cumulative cost basis has grown at a 25.7% compound annual growth rate (CAGR), from $198.26M to $494.56M.